THC is the ticker symbol for TENET HEALTHCARE CORP, a publicly traded Healthcare sector company listed on NYSE. 13F Pro tracks THC with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is THC a good stock to buy?

13F Pro's AI ranking engine scores THC at 65.4/100, ranked #477 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for THC is available at https://13fpro.ai/company/THC. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source THC data?

All TENET HEALTHCARE CORP fundamentals and ownership data come directly from SEC EDGAR. TENET HEALTHCARE CORP files with the SEC under CIK 70318. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

TENET HEALTHCARE CORP THC

NYSELarge CapHealthcare

13F Pro quality score

Rank #477 of 2,925TOP 25%

Why it scores 65 Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$5.63B

Quarter to Jun 30

Net income

$1.04B

Quarter to Jun 30

Free cash flow

$417.00M

Quarter to Jun 30

Operating margin

26.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026

$15.05B total

BlackRock, Inc.

$1.64B+0.4%

PRICE T ROWE ASSOCIATES INC /MD/

$1.49B+5.8%

Boston Partners

$829.06M+15.6%

VANGUARD PORTFOLIO MANAGEMENT LLC

$792.87M-1.8%

FMR LLC

$747.30M-48.6%

VANGUARD CAPITAL MANAGEMENT LLC

$728.52M-0.4%

STATE STREET CORP

$514.71M+1.3%

GLENVIEW CAPITAL MANAGEMENT, LLC

$418.25M+46.6%

GEODE CAPITAL MANAGEMENT, LLC

$352.72M-2.4%

CITADEL ADVISORS LLC

$330.31M+321.6%

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

$319.62M+154.3%

AMERIPRISE FINANCIAL INC

$311.46M+11.5%

DIMENSIONAL FUND ADVISORS LP

$271.35M+20.8%

Invesco Ltd.

$265.08M-20.7%

VICTORY CAPITAL MANAGEMENT INC

$231.59M+61.2%

NORGES BANK

$227.16M--

AQR CAPITAL MANAGEMENT LLC

$198.27M-26.0%

ALLIANCEBERNSTEIN L.P.

$171.78M+30.2%

MANNING & NAPIER ADVISORS LLC

$168.76MNew

BANK OF AMERICA CORP /DE/

$159.93M+10.8%

MORGAN STANLEY

$155.58M+4.5%

T. Rowe Price Investment Management, Inc.

$148.52M+321.1%

NORTHERN TRUST CORP

$146.16M-0.5%

Pentwater Capital Management LP

$143.12M+512.0%

Allianz Asset Management GmbH

$142.21M-1.9%

See all 687 institutional holders →

What's Driving THC's Business? Latest 10-Q Breakdown

15/15 datapoints verified

AI-extracted from the 10-Q filed 2026-07-29 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Tenet's Q2 revenue rose 6.8% YoY to $5.628B, but operating income nearly doubled to $1.501B largely because of a one-time $413M contract-termination payment from the CHI/Conifer settlement.

Biggest Revenue Drivers

Hospital Operations$4,240M+6.0% YoY

Higher patient volumes, partially offset by a less favorable payer mix

Ambulatory Care$1,388M+9.3% YoY

Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases

Biggest Revenue Drivers

Total revenue: $5.628B+6.8% YoY

Hospital Operations$4,240M+6.0% YoY

Higher patient volumes, partially offset by a less favorable payer mix

Within Hospital Operations

Managed care$2,470M+1.9% YoY

Includes Medicare and Medicaid managed care programs

Medicaid$505M+33% YoY

Growth tied to DSH and other supplemental program revenue

Ambulatory Care$1,388M+9.3% YoY

Driven by 2025/2026 acquisitions, de novo development and same-facility commercial rate increases

Largest Expense Items

Salaries, wages and benefits$2,231M+3.3% YoY

Annual merit increases and higher incentive compensation, partly offset by lower health benefits cost

Supplies$984M+5.6% YoY

Higher patient volumes, partially offset by cost-efficiency measures

Other operating expenses, net$1,174M+4.9% YoY

Increases in malpractice expense and medical fees

Margins: Operating margin expanded to 26.7% from 15.6% a year ago, but the filing attributes 7.3 percentage points of revenue to the one-time contract-termination payment, meaning underlying margin improvement is smaller than the headline suggests.

Watch Items from the Filing

$413M of Q2 revenue came from a one-time contract-termination payment tied to the CHI/Conifer Omnibus Agreement, not recurring operations.
Managed care fell to 67.3% of net patient service revenue from 70.2% while Medicaid rose to 13.8% from 11.0%, a less favorable payer mix shift.
OBBBA Medicaid provisions taking effect mostly in 2027 (work requirements, provider tax limits, state-directed payment caps) could materially reduce future Medicaid payments; Tenet cannot yet estimate the impact.
Repurchased 5.675 million shares for $1.042 billion in the quarter, with $2.130 billion still authorized after a $2.0 billion increase in June 2026.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Debt/Equity

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/THC

Earnings Per Share

13fpro.ai/company/THC

Loading ratio trend…

TENET HEALTHCARE CORP reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$21.3B	$2.4B	16.5%
FY 2024	10-K	$20.7B	$4.1B	28.8%
FY 2023	10-K	$20.6B	$1.3B	12.2%
FY 2022	10-K	$19.2B	$1.0B	12.2%
FY 2021	10-K	$19.5B	$1.5B	14.7%
FY 2020	10-K	$17.6B	$768.0M	11.3%

About TENET HEALTHCARE CORP (THC): stock profile, AI score and financials

TENET HEALTHCARE CORP (THC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores THC at 65.4/100 on a composite quality score built from its SEC filings, placing it at rank #477 of 2,925 stocks — the top 25% of the AI-ranked universe. THC scores in the top quartile across revenue scale (93.1), balance sheet strength (84.9), institutional flow (76.2). Areas of concern include revenue growth (31.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), TENET HEALTHCARE CORP reports quarterly revenue of $5.6B, net income of $1.0B, an operating margin of 26.7%. Top institutional holders of THC by reported 13-F value include BlackRock, PRICE T ROWE ASSOCIATES, Boston Partners, based on the most recent SEC filings. THC trades on the NYSE exchange and files with the SEC under CIK 70318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate THC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENET HEALTHCARE CORP directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 70318 →

TENET HEALTHCARE CORP THC

Top Institutional Holders

What's Driving THC's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Biggest Revenue Drivers

Largest Expense Items

Watch Items from the Filing

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

THC key financials by period

THC insiders

Congress trading in THC

About TENET HEALTHCARE CORP (THC): stock profile, AI score and financials

TENET HEALTHCARE CORP THC

Top Institutional Holders

What's Driving THC's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

THC key financials by period

Companies similar to THC

THC insiders

Congress trading in THC

About TENET HEALTHCARE CORP (THC): stock profile, AI score and financials